(PIRS) Pieris Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Pieris Pharmaceuticals | (PIRS) share price targets
Complete technical analysis of Pieris Pharmaceuticals (PIRS) by charts plus indicators, forecast predictions and share price targets for Pieris Pharmaceuticals (PIRS)
Pieris Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-05-10 View latest technical analysis
10 day averaged volume of Pieris Pharmaceuticals is 24560
| Date | Daily Closing Price | Open | High | Low | Volume |
| 10 Fri May 2024 | 11.15 | 11.00 | 11.26 | 11.00 | 0.346 times |
| 09 Thu May 2024 | 11.16 | 11.32 | 11.32 | 11.16 | 0.086 times |
| 08 Wed May 2024 | 11.14 | 10.90 | 11.25 | 10.90 | 0.362 times |
| 07 Tue May 2024 | 11.04 | 10.99 | 11.18 | 10.87 | 0.436 times |
| 06 Mon May 2024 | 11.06 | 11.05 | 11.41 | 10.80 | 0.692 times |
| 03 Fri May 2024 | 11.08 | 10.98 | 11.20 | 10.60 | 1.283 times |
| 02 Thu May 2024 | 11.24 | 11.28 | 11.59 | 10.82 | 3.322 times |
| 01 Wed May 2024 | 11.68 | 11.68 | 11.94 | 11.50 | 1.958 times |
| 30 Tue Apr 2024 | 11.71 | 11.64 | 11.90 | 11.62 | 0.566 times |
| 29 Mon Apr 2024 | 11.71 | 11.94 | 12.14 | 11.53 | 0.607 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 13.2 as stoploss in an intra day sell trade for a target of 8.06. However, stock will show a bullish move above 13.2.
Share price targets for Pieris Pharmaceuticals (PIRS)
| Target Type | Value |
| Downside Target | 0.14 |
| Downside Target | 0.15 |
| Downside Target | 0.16 |
| Downside Target | 0.17 |
| Downside Target | 0.18 |
| Downside Target | 0.19 |
| Downside Target | 0.28 |
| Downside Target | 10.60 |
| Downside Target | 10.80 |
| Upside Target | 11.41 |
| Upside Target | 11.94 |
| Upside Target | 12.14 |
| Upside Target | 12.93 |
Intraday share price targets for Pieris Pharmaceuticals (PIRS)
| Target Type | Value |
| Downside Intraday Target | 10.83 |
| Downside Intraday Target | 10.51 |
| Upside Intraday Target | 11.44 |
| Upside Intraday Target | 11.73 |
| Downside Intraday Target | 11.12 |
Weekly technical analysis of Pieris Pharmaceuticals (PIRS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 10 Fri May 2024 | 11.15 | 11.05 | 11.41 | 10.80 | 0.248 times |
| 03 Fri May 2024 | 11.08 | 11.94 | 12.14 | 10.60 | 0.091 times |
| 26 Fri Apr 2024 | 11.72 | 0.15 | 12.93 | 0.14 | 0.503 times |
| 19 Fri Apr 2024 | 0.15 | 0.17 | 0.18 | 0.14 | 3.085 times |
| 12 Fri Apr 2024 | 0.17 | 0.18 | 0.19 | 0.17 | 0.57 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Pieris Pharmaceuticals (PIRS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 10 Fri May 2024 | 11.15 | 11.68 | 11.94 | 10.60 | 0.021 times |
| 30 Tue Apr 2024 | 11.71 | 0.19 | 12.93 | 0.14 | 0.413 times |
| 28 Thu Mar 2024 | 0.18 | 0.17 | 0.28 | 0.16 | 4.031 times |
| 29 Thu Feb 2024 | 0.17 | 0.19 | 0.19 | 0.15 | 0.873 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Pieris Pharmaceuticals (PIRS)
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Pieris Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Pieris Pharmaceuticals in short term but the sell signal is initial and weak.
Pieris Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Pieris Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Pieris Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.34 and Pieris Pharmaceuticals (PIRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Pieris Pharmaceuticals (PIRS) stock. Volume based technical analysis of Pieris Pharmaceuticals (PIRS) stock is negative.
Pieris Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Pieris Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Pieris Pharmaceuticals in short term but the sell signal is initial and weak.
Pieris Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Pieris Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Pieris Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.34 and Pieris Pharmaceuticals (PIRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Pieris Pharmaceuticals (PIRS) stock. Volume based technical analysis of Pieris Pharmaceuticals (PIRS) stock is negative.
Pieris Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.